A landmark Phase 3 trial has begun in the UK and US to test Moderna’s mRNA-1018 vaccine against the H5N1 bird flu strain, a virus with pandemic potential. The study will assess safety and immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results